In a murine orthotopic model of HNSCC, fractionated conformal radiotherapy could sensitize anti-PD-L1-resistant tumors, and a combination of radiotherapy with PD-L1 blockade resulted in a significant enhancement in tumor control and improvement in survival when compared with monotherapy (65). Here, CD274 is linked to head and neck squamous cell carcinoma.